novo nordisk glp-1 receptor agonist RA education ANSE1024_0051_table_a.jpg

Y.ThorwaldM.Godoy-LugoJ

[DOI] [PubMed] [Google Scholar] 272.Tahrani, A

For self-application without assistance, the upper arm, chest, and abdomen are typically most accessible

By Robert Barrie

Previously, GLP-1 medications which mimic the naturally occurring hormone glucagon-like peptide-1, which regulates blood sugar, digestion, and hunger had been approved only to treat obesity in the form of weekly, home-administered injections

Final Verdict: Worth It for Some, Dangerous for Others The GLP-1 revolution is real, and for some patientsparticularly those with type 2 diabetes and obesity-related cardiovascular diseasethese medications represent a genuine breakthrough